Login to Your Account

Pharmasset Stock Hits 52-Week High on HCV Data

By Marie Powers

Wednesday, March 9, 2011
Health care conference abstracts don't usually drive stock prices, but investors in Pharmasset Inc. took notice this week when abstracts were posted for the European Association for the Study of the Liver (EASL) conference, scheduled to begin on March 30 in Berlin.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription